Article Information
History
- November 18, 2020.
Article Versions
- Version 1 (September 21, 2020 - 12:54).
- Version 2 (October 22, 2020 - 14:24).
- Version 3 (November 13, 2020 - 11:01).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Bhautesh D Jani, PhD, Clinical Senior Lecturer in General Practice and Primary Care†,1,
- Frederick K Ho, PhD, Research Associate†,2,
- David J Lowe, MSc, Consultant in Emergency Medicine3,
- Jamie P Traynor, MD, Consultant Nephrologist3,
- Sean MacBride-Stewart, PhD, Lead Pharmacist (Medicines Management Resources)4,
- Patrick B Mark, PhD, Professor of Nephrology5,
- Frances S Mair, MD, Norie Miller Professor of General Practice1 and
- Jill P Pell, MD, Henry Mechan Professor of Public Health*,2
- 1Institute of Health and Wellbeing, University of Glasgow, Glasgow G12 9LX, UK
- 2Institute of Health and Wellbeing, University of Glasgow, Glasgow, G12 8RZ, UK
- 3Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, G52 4TF, UK
- 4Pharmacy Services, NHS Greater Glasgow and Clyde, Glasgow, G76 7AT, UK
- 5Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, G12 8TA, UK
- ↵*Address for correspondence:
Professor Jill Pell, Director of the Institute of Health and Wellbeing, University of Glasgow, 1 Lilybank Gardens, Glasgow G12 8RZ, United Kingdom, Jill.pell{at}glasgow.ac.uk
Posted November 18, 2020.
Comparison of COVID-19 outcomes among shielded and non-shielded populations: A general population cohort study of 1.3 million
